Literature DB >> 15001508

Severe cholestatic hepatitis induced by pyritinol.

Vasco Maria1, Adriana Albuquerque, Ana Loureiro, Ana Sousa, Rui Victorino.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15001508      PMCID: PMC381054          DOI: 10.1136/bmj.328.7439.572

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  8 in total

1.  Acute hepatitis due to pyritinol.

Authors:  G Macedo; J A Sarmento; S Allegro
Journal:  Gastroenterol Clin Biol       Date:  1992

2.  Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis.

Authors:  V A Maria; R M Victorino
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

3.  Drug-related hepatitis.

Authors:  S Imoto; H Matsumoto; M Fujii
Journal:  Ann Intern Med       Date:  1979-07       Impact factor: 25.391

4.  Marked immunosuppressive effects of the HIV-2 envelope protein in spite of the lower HIV-2 pathogenicity.

Authors:  R Cavaleiro; A E Sousa; A Loureiro; R M Victorino
Journal:  AIDS       Date:  2000-12-01       Impact factor: 4.177

5.  Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury.

Authors:  V A Maria; R M Victorino
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

6.  Comparison of pyritinol and auranofin in the treatment of rheumatoid arthritis. The European Multicentre Study Group.

Authors:  E M Lemmel
Journal:  Br J Rheumatol       Date:  1993-05

Review 7.  Adverse effects profile of sulfhydryl compounds in man.

Authors:  I A Jaffe
Journal:  Am J Med       Date:  1986-03       Impact factor: 4.965

8.  Acute pancreatitis due to pyritinol: an immune-mediated phenomenon.

Authors:  A Straumann; M Bauer; W J Pichler; M Pirovino
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.